NCT04791319 · Interventional trial
A Study of Bermekimab (JNJ-77474462) in the Treatment of Participants With Moderate to Severe Atopic Dermatitis
Overall registry status Terminated
Phase 2
Conditions Dermatitis, Atopic
Delaware Valley sites
- Psoriasis Treatment Center of Central New Jersey · East Windsor, NJ · Mercer County
First posted
Registry updated
Added to the directory